AAFP Tips on Getting Shots into Arms this Flu Season with Sterling Ransone, Jr, MD
AAFP Board Chair Sterling Ransone, Jr, MD, offers an Academy refresher on the annual push-back from patients that is so familiar to family medicine clinicians.
Tezepelumab Reduced Exacerbations in Severe, Uncontrolled Asthma, Regardless of Number of Additional Controller Medications
CHEST 2022. Tezepelumab significantly reduced AAER and improved lung function in patients taking 1, 2, or ≥3 long-acting β-agonists in addition to ICS.
Will This be the Year of the Twindemic? AAFP Board Chair Ransone Thinks Out Loud with Patient Care
About half of American adults plan not to get a flu shot this year; everyone is tired of COVID talk and prevention; but flu is brewing in the southern hemisphere, Ransone says.
More Readmissions in Women than Men after Acute Myocardial Infarction, New Study Finds
Findings underscore the need for ongoing efforts to improve prevention strategies, as CVD risk factors in younger women continue to rise, according to authors.
The Daily Dose: Adult RSV Vaccine
Your daily dose of clinical news from Patient Care Online.
Early Diabetes Diagnosis in Women Associated with Early Age at Menopause in Large Canadian Cohort
Early age at either type 1 or type 2 diabetes diagnosis was associated with earlier age a menopause, suggesting an impact of diabetes on reproductive health, authors say.
The Daily Dose: CVD Risk Factors Linked to COVID-19 Death
AAFP Board Chair Sterling Ransone, Jr, MD, Has Concerns About Flu Season 2022-2023
Ransone hasn't had a case of influenza in his practice in 2 years, but with mitigation measures all but over and COVID-19 in the wings, this year could be different.
All Health Care Professionals Can Support One Another's Mental Health, Expert Says
Not every physician has to be a mental health expert to assist their colleagues, staff, and patients in improving their mental well-being. Just start the conversation.
GSK Announces Positive Pivotal Phase 3 Data for Adult RSV Vaccine Candidate
The investigational respiratory syncytial virus vaccine had an overall efficacy of 82.6% against RSV-LRTD, 94.6% against severe disease, and 94.1% in adults with comorbidities.
USPSTF Issues Final Recommendations for Anxiety, Depression Screening in Youth
For the first time, the task force recommended screening children aged 8 and older for anxiety in primary care settings.
CVD Risk Factors May Pose Greater Risk for COVID-19 Mortality than Preexisting Heart Disease
Smoking, age, diabetes, race/ethnicity, and BMI may all pose a greater risk for mortality in severe COVID-19 infection than preexisting CVD, study suggests.
Physician Wellbeing: Current State & Solutions to Improve It
There was no change in physician burnout in the past year and it remains significantly higher than pre-pandemic times, according to a new nationwide survey.
FDA Expands EUA for Bivalent COVID-19 Vaccines to Include Children as Young as Age 5 Years
The FDA amended EUAs for omicron-adapted vaccines from both Pfizer and Moderna, authorizing the shots for children and adolescents.
The Daily Dose: IBS Phenotypes
COVID-19 Vaccines, Boosters, Prior Infection Significantly Reduce Risks, but Immunity Wanes
A large cohort study confirms the observed efficacy of initial and follow-up COVID-19 vaccination and prior infection against infection, hospitalization, and death.
The Daily Dose from Patient Care Online: October 12, 2022
Irritable Bowel Syndrome Cohort Analysis Identifies 7 Distinct Latent Subsets
Identification of unique IBS subsets has implications for more individualized treatment as well as approaches to clinical trials, say study authors.
Cardiometabolic Disease Update: 12 Studies
Studies of cardiometabolic disease pathophysiology, prevention, and treatment make science news every day. Find 12 here, at-a-glance.
Remdesivir for Severe COVID-19: Expert Guidance on Use in Clinical Practice
Elizabeth Sapey, PhD, discusses how the updated treatment recommendations from the World Health Organization may impact future use of remdesivir.
